文献速递骨肌胸部CT

糖尿病与常规CT深度学习得出的椎体骨密度纵向变化:动脉粥样硬化多种族研究

Diabetes and longitudinal changes in deep learning-derived measures of vertebral bone mineral density using conventional CT: the Multi-Ethnic Study of Atherosclerosis.
PubMed 文献 · Skeletal Radiol · 2025-07-29

研究纳入动脉粥样硬化多种族研究肺亚组1046名参与者,用深度学习模型从第5次(2010-2012年)和第6次(2016-2018年)胸部CT分割胸椎骨小梁并测量体积骨密度。糖尿病患者基线椎体骨密度更高(202 vs. 190 mg/cm3),中位随访6.2年间骨密度显著上升(β=0.62 mg/cm3/年;95% CI 0.26, 0.98),合并肾功能减退的糖尿病患者上升更明显(β=1.52 mg/cm3/年;95% CI 0.66, 2.39)。

要点

  • 糖尿病患者基线椎体骨密度高于非糖尿病者(202 vs. 190 mg/cm3)。
  • 糖尿病组随访期间椎体骨密度显著上升,β=0.62 mg/cm3/年(95% CI 0.26, 0.98)。
  • 合并肾功能减退的糖尿病患者骨密度上升更明显,β=1.52 mg/cm3/年。

核心结论

  • 糖尿病患者椎体骨密度随时间上升,且合并糖尿病肾病者上升更明显;作者认为常规骨密度测量可能无法完全反映糖尿病中已知的骨折风险,并提出需结合先进影像评估骨微结构及骨折结局的进一步研究。

研究设计与样本

  • 纵向研究,纳入动脉粥样硬化多种族研究肺亚组1046名参与者,使用经过验证的深度学习模型从常规胸部CT分割胸椎骨小梁并计算体积骨密度,采用线性混合效应模型分析糖尿病与骨密度随时间变化的关联。

诊断标准与关键数值

  • 糖尿病按美国糖尿病协会标准分类,空腹血糖受损(即糖尿病前期)者被排除。
  • 肾功能按eGFR分为≥60 vs. <60 mL/min/体表面积两组进行分层分析。
  • 糖尿病组骨密度年变化β=0.62 mg/cm3/年(95% CI 0.26, 0.98),中位随访6.2年。
  • 合并肾功能减退的糖尿病组β=1.52 mg/cm3/年(95% CI 0.66, 2.39),肾功能保留的糖尿病组β=0.48 mg/cm3/年(95% CI 0.10, 0.85)。

局限性

  • 作者指出需进一步研究结合先进影像评估骨微结构及骨折结局,以完善糖尿病人群的骨骼健康评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the longitudinal association between diabetes and changes in vertebral bone mineral density (BMD) derived from conventional chest CT and to evaluate whether kidney function (estimated glomerular filtration rate (eGFR)) modifies this relationship.

MATERIALS AND METHODS: This longitudinal study included 1046 participants from the Multi-Ethnic Study of Atherosclerosis Lung Study with vertebral BMD measurements from chest CTs at Exam 5 (2010-2012) and Exam 6 (2016-2018). Diabetes was classified based on the American Diabetes Association criteria, and those with impaired fasting glucose (i.e., prediabetes) were excluded. Volumetric BMD was derived using a validated deep learning model to segment trabecular bone of thoracic vertebrae. Linear mixed-effects models estimated the association between diabetes and BMD changes over time. Following a significant interaction between diabetes status and eGFR, additional stratified analyses examined the impact of kidney function (i.e., diabetic nephropathy), categorized by eGFR (≥ 60 vs. < 60 mL/min/body surface area).

RESULTS: Participants with diabetes had a higher baseline vertebral BMD than those without (202 vs. 190 mg/cm3) and experienced a significant increase over a median followpup of 6.2 years (β = 0.62 mg/cm3/year; 95% CI 0.26, 0.98). This increase was more pronounced among individuals with diabetes and reduced kidney function (β = 1.52 mg/cm3/year; 95% CI 0.66, 2.39) compared to the diabetic individuals with preserved kidney function (β = 0.48 mg/cm3/year; 95% CI 0.10, 0.85).

CONCLUSION: Individuals with diabetes exhibited an increase in vertebral BMD over time in comparison to the non-diabetes group which is more pronounced in those with diabetic nephropathy. These findings suggest that conventional BMD measurements may not fully capture the well-known fracture risk in diabetes. Further studies incorporating bone microarchitecture using advanced imaging and fracture outcomes are needed to refine skeletal health assessments in the diabetic population.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Ghotbi E, Hadidchi R, Hathaway QA, et al. Diabetes and longitudinal changes in deep learning-derived measures of vertebral bone mineral density using conventional CT: the Multi-Ethnic Study of Atherosclerosis. Skeletal Radiol. 2025. PMID: 40728733. doi:10.1007/s00256-025-04995-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。